Comments
Pharma major Dr Reddy's Laboratories Ltd will be launching anti-hypertension drug, Optidoz, in the domestic market.
The drug was approved by the Drug Controller General of India, Alok Sonig, Head of India Generics, Dr Reddy's told newspersons here on Friday.
It is a single pill combination of three anti-hypertensive drugs - amlodipine, telmisartan and hydrochlorothiazide with optimal dose of individual drugs.
"Efficacy and safety of Optidoz has been established through Control-hypertension clinical study approved by DGCI," the company said.
The drug is priced at Rs 80 per a strip of 10 tablets.
naga.gunturi@thehindu.co.in
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.